Skip to main content

Exact Sciences Value Stock - Dividend - Research Selection

Exact sciences

ISIN: US30063P1057 , WKN: 590273

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Geneoscopy Files Counterclaims against Exact Sciences

2024-07-02
ST, LOUIS, MO - Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, filed a lawsuit asserting multiple claims for damages...

Exact Sciences : EEO-1 for the FY ended 12/19/2023

2024-06-28
Exact Sciences is committed to disclosing meaningful information regarding our efforts to create a diverse, equitable, and inclusive workplace. To us, diversity means our team reflects a variety of...

Exact Sciences : EEO-1 for the FY ended 12/29/2020

2024-06-28
Exact Sciences is committed to disclosing meaningful information regarding our efforts to create a diverse, equitable, and inclusive workplace. To us, diversity means our team reflects a variety of...

Exact Sciences : EEO-1 for the FY ended 12/19/2021

2024-06-28
Exact Sciences is committed to disclosing meaningful information regarding our efforts to create a diverse, equitable, and inclusive workplace. To us, diversity means our team reflects a variety of...

Exact Sciences : EEO-1 for the FY ended 12/19/2022

2024-06-28
Exact Sciences is committed to disclosing meaningful information regarding our efforts to create a diverse, equitable, and inclusive workplace. To us, diversity means our team reflects a variety of...

Dynatrace initiated, U.S. Bancorp downgraded: Wall Street's top analyst calls

2024-06-27
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Jefferies Sticks to Their Buy Rating for Exact Sciences (EXAS)

2024-06-27
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Scotiabank starts Exact Sciences with Outperform, sees 'plenty of runway'

2024-06-27
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Exact Sciences initiated at sector outperform at Scotiabank on advanced diagnostics

2024-06-27
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Exact Sciences (EXAS) Receives a Buy from BTIG

2024-06-26
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.